Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic neuropathies.

Patrick M Grogan1, Jonathan S Katz

  • 1Department of Neurology, Wilford Hall Medical Center, San Antonio, TX 78236, USA. patrick.grogan@lackland.af.mil

Neurologic Clinics
|March 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laboratory Evaluation of Peripheral Neuropathy.

Neurologic clinics·2025
Same author

Chronic Inflammatory Demyelinating Polyneuropathy and Variants.

Neurologic clinics·2025
Same author

Immune-Mediated Neuropathies Other Than Typical Chronic Inflammatory Demyelinating Polyradiculoneuropathy-Multifocal Motor Neuropathy, Autoimmune Nodopathies, Anti-Myelin Associated Glycoprotein Neuropathy, Chronic Inflammatory Sensory Polyradiculoneuropathy, and Chronic Ataxic Neuropathy with Ophthalmoplegia, M-Protein, Agglutinin, and Disialosyl Antibodies.

Neurologic clinics·2025
Same author

A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS.

Annals of clinical and translational neurology·2022
Same author

A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.

Muscle & nerve·2021
Same author

Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2020
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Exposure to various substances can cause toxic peripheral neuropathies, typically presenting as painful sensory or sensorimotor polyneuropathy. Management focuses on toxin avoidance, with gradual improvement often observed after removal.

Area of Science:

  • Neuroscience
  • Toxicology

Background:

  • Peripheral nerve damage can result from exposure to numerous organic and manufactured substances.
  • These exposures often lead to a distal, painful polyneuropathy with axonal characteristics.

Purpose of the Study:

  • To review the clinical presentation and management of toxic peripheral neuropathies.

Main Methods:

  • Review of clinical phenotypes.
  • Analysis of electrodiagnostic and histopathologic findings.
  • Discussion of treatment strategies.

Main Results:

  • Toxic neuropathies commonly manifest as distal sensory or sensorimotor polyneuropathies.
  • Axonal damage is a characteristic finding.
  • Treatment is primarily supportive, focusing on toxin avoidance.

Related Experiment Videos

Conclusions:

  • Effective management relies on identifying and removing the causative toxin.
  • Most toxic neuropathies are self-limited and show gradual improvement post-elimination.